Category: News

Discordance in Platinum and PARPi Response in Ovarian Cancer

Platinum and PARP inhibitor (PARPi) sensitivity commonly coexist in epithelial ovarian cancer (EOC) due to the high prevalence of alterations in the homologous recombination (HR) DNA repair pathway that confer sensitivity to both drugs. In this report...

GOLPH3 Links the Golgi, DNA Damage, and Cancer

GOLPH3 is the first example of an oncogene that functions in secretory trafficking at the Golgi. The discovery of GOLPH3′s roles in both cancer and Golgi trafficking raises questions about how GOLPH3 and the Golgi contribute to cancer. Our recent in...

miRNA-29c Predicting Gastric Cancer Chemotherapy

Chemotherapy has improved the survival of patients with gastric cancer by unknown mechanisms. In this study, we showed that cisplatin and docetaxel used in gastric cancer treatment increase the expression of miRNA-29 (miR-29) family members and decrea...

Chemotherapy-induced miRNA-29c/catenin-{delta} signaling suppresses metastasis in gastric cancer

Chemotherapy has improved the survival of gastric cancer (GC) patients by unknown mechanisms. In this study, we showed that cisplatin and docetaxel used in GC treatment increase expression of miRNA-29 family members (miR-29s) and decrease expression of...

miRNA-Mediated Impairment of Metastatic Bone Disease

Progression of breast cancer to metastatic bone disease is linked to deregulated expression of the transcription factor Runx2. Therefore, our goal was to evaluate the potential for clinical use of Runx2-targeting miRNAs to reduce tumor growth and bone...